Metastatic Malignant Neoplasm to the Leptomeninges

DBCOND0057483Immune System Diseases Infections

Metastatic Malignant Neoplasm to the Leptomeninges is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Lymphomatous meningitis · Leptomeningeal Metastases · Neoplastic Meningitis · Leptomeningeal Carcinomatosis · Leptomeningeal Metastasis
Classified under: Immune System Diseases
Infections
Neoplasms
Nervous System Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Cytarabine

Resolves to

Vocabularies

MeSHM0520188SNOMED CT1155991005MedDRA10024233UMLSC0220654

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

103Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Metastatic Malignant Neoplasm to the Leptomeninges share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account